Report cover image

Molecular Diagnostics for Neurodegenerative Diseases: Technology Growth Opportunities, 2024–2028

Publisher Frost & Sullivan
Published Jun 19, 2024
SKU # MC18925787

Description

Molecular Diagnostics for Neurodegenerative Diseases: Technology Growth Opportunities, 2024–2028


Leveraging integrated and point-of-care diagnostics with multiomics represents the most promising growth opportunity to advance molecular diagnostics for neurodegenerative diseases

Neurodegenerative diseases (NDD) pose significant challenges to healthcare systems and affect millions of people worldwide, making early detection crucial. While the current diagnostic strategy is predominantly brain imaging techniques, it is not performed until symptoms are more pronounced. Subtle changes occurring in neural cells during early progression cannot be detected by the structural or functional changes associated with NDDs.

This study is a comprehensive analysis that explores technological advancements, industry dynamics, strategic insights, and growth opportunities in molecular diagnostics for NDDs. It captures the role of leading companies, growing start-ups, and smaller companies with innovative product portfolios and an industry presence, key drivers and restraints, and strategic partnerships. The study also delves into funding, grants, mergers and acquisitions (M&As), and commercialization efforts.

Overall, this study aims to provide insights into the evolving landscape of molecular diagnostics for NDDs and implications for healthcare innovation and patient care.

Key Questions the Study Answers:
1. What are the different molecular diagnostics for NDDs?
2. What are the main challenges and complexities in the widespread adoption of molecular diagnostics compared to imaging diagnostics?
3. What are the primary sources of biomarkers used in NDDs? Who are the key and emerging participants in terms of innovation and technology in this space?
4. How are omics technologies, smart PoC devices, and exosome-mediated diagnoses emerging as novel molecular diagnostics modalities for NDDs? How do they improve accuracy?
5. What are the strategic implications of the emerging collaborations and M&As between academia and industry participants?
6. How do patents contribute to advancements in diagnostics and therapeutics for NDDs?
7. What are the growth opportunities for molecular diagnostics for NDDs?

Table of Contents

    • Why Is It Increasingly Difficult to Grow?
    • The Strategic Imperative 8
    • The Impact of the Top 3 Strategic Imperatives on Molecular
    • Growth Opportunities Fuel the Growth Pipeline Engine
    • Research Methodology
    • Dementia Disease Burden Forecast for 2050
    • Insights into NDD Research: Trends in Publications and Clinical Trials, 2019–2024
    • NDDs: Overview and Importance of Early Diagnosis
    • Segmentation
    • Challenges in Early NDD Diagnosis
    • Diagnostic Modalities in the NDD Landscape
    • Sources of NDD Molecular Biomarkers
    • Scope of Analysis
    • NDD Diagnosis: Biomarker Sources, Sample Extraction, and Analytes
    • Biomarker Sources: A Comparative Analysis
    • Integrated Landscape of NDD Biomarkers
    • Growth Drivers
    • Growth Restraints
    • CSF-based Molecular Diagnostics to Detect NDDs
    • Key Companies Developing CSF-based Molecular Diagnostics for NDDs
    • Emerging Company Developing CSF-based Molecular Diagnostics for NDDs
    • Key Biomarkers for Neurodiagnostics: CSF-based Biomarkers, Global, 2024
    • Blood-based Biomarkers in NDD Diagnosis
    • Key Companies Developing Blood-based Molecular Diagnostics for NDDs
    • Emerging Companies Developing Blood-based Molecular Diagnostics for NDDs
    • Key Biomarkers for Neurodiagnostics: Blood-based Biomarkers, Global, 2024
    • Salivary Biomarkers: An Accessible and Painless Diagnostic Approach for NDDs
    • Emerging Companies Developing Saliva-based Molecular Diagnostics for NDDs
    • Urinary Biomarkers for Early Diagnosis of NDDs
    • Emerging Companies Developing Urine-based Molecular Diagnostics for NDDs
    • Ocular Biomarkers: A New Frontier in NDD Diagnosis
    • Neurobiomarkers: Molecular Alterations in the Ocular Space
    • Emerging Companies Developing Ocular-based Molecular Diagnostics for NDDs
    • Skin-based Biomarkers for NDDs
    • Key Insights: Biomarker Utilization by Industry Participants in the NDD Diagnostics Space
    • Molecular Biomarkers: From Bench to Clinic, Impact Analysis
    • Notable Clinical Trials in NDD Molecular Diagnostics
    • European Platform for Neurodegenerative Disorders (EPND): A Collaborative Approach to Data and Sample Sharing
    • Databases and Biobanks: Catalysts for Biomarker Discovery in NDD Diagnosis
    • Epigenetic Alterations as NDD Biomarkers
    • Big Data-powered Multiomics for NDD Diagnosis
    • Exosomes: A Potential Candidate for Early NDD Diagnosis
    • Portable Molecular Diagnostic Devices Enabling Smart Diagnostics for NDDs
    • Synaps Dx, US
    • AgenT Biotech, France
    • Urvogelbio, India
    • Resonant, US
    • Neurodex, US
    • Notable NDD Diagnostics Collaborations and Clinical Alliances
    • Recent NDD Diagnostics Mergers and Acquisitions
    • Global Companies in NDD Diagnostics: Insight into Regional Adoption
    • Snapshot of Public Funding for Molecular Diagnostics of NDDs in the US, 2019–2024
    • Special Focus on NIH Funding for Molecular Diagnostics of AD, 2019– 2024
    • EU R&D Projects, 2019–2023
    • Snapshot of Private Funding for Molecular Diagnostics of NDDs, 2021– 2024
    • Snapshot of Private Funding for Molecular Diagnostics of NDDs, 2020– 2023
    • IP Trends in the Molecular Neurobiomarker Industry, 2019–2024
    • Patents by Key Participants in the NDD Diagnostics Space, 2019–2024
    • Analysis of IP Trends in the Molecular Neurobiomarker Industry, 2019–2024
    • Analyst Perspectives
    • Molecular Diagnostics in NDDs: Technology, Innovation, and Application Impact Analysis
    • Commercial Availability of Different Molecular Diagnostic Technologies in the NDD Landscape
    • Molecular Diagnosis of NDDs: A Technology Road Map
    • Growth Opportunity 1: Smart Diagnostics at the Point of Care for NDD Detection and Management
    • Growth Opportunity 2: Integrated Diagnostics for Comprehensive NDD Assessment
    • Growth Opportunity 3: Exosomics and Metabolomics in the NDD Space
    • Technology Readiness Levels (TRLs): Explanation
    • Benefits and Impacts of Growth Opportunities
    • Next Steps
    • Take the Next Step

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us